Genmab A/S (GMAB)

Chimerix Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	1,140	1,089	645.39	783.33	452.29	781.94
Depreciation & Amortization	62.84	57.33	43.75	52.01	29.67	43.71
Asset Writedown & Restructuring Costs	8.66	15.96	-	-	-	4.77
Loss (Gain) From Sale of Investments	-7.79	-34.29	-43.45	94.54	105.39	-143.47
Stock-Based Compensation	105.47	100.09	86.9	63.07	47.42	32.87
Other Operating Activities	-21.83	-46.78	159.86	-166.52	-186.15	175.19
Change in Accounts Receivable	-145.38	-220.73	118.19	-305.03	-154.33	50.29
Change in Inventory	3.28	-0.69	-8.45	-	-	-
Change in Accounts Payable	49.17	118.97	92.24	40.66	46.5	27.61
Change in Unearned Revenue	-	-	-	-	-	84.31
Operating Cash Flow	1,194	1,079	1,094	562.07	340.79	1,057
Operating Cash Flow Growth	45.87%	-1.43%	94.72%	64.93%	-67.77%	430.89%
Capital Expenditures	-35.09	-25.96	-54.28	-45.55	-38.55	-50.45
Cash Acquisitions	-1,774	-1,700	-	-	-	-
Sale (Purchase) of Intangibles	-34.95	-16.24	-1.48	-	-	-
Investment in Securities	575.94	366.91	-134.36	-351.15	-108.45	-335.91
Investing Cash Flow	-1,268	-1,375	-190.12	-396.7	-146.99	-386.37
Long-Term Debt Repaid	-	-8.33	-13.5	-10.49	-8.87	-7.23
Net Debt Issued (Repaid)	-7.69	-8.33	-13.5	-10.49	-8.87	-7.23
Issuance of Common Stock	10.69	17.91	22.54	40.23	20.65	23.01
Repurchase of Common Stock	-498.82	-553.62	-98.91	-143.1	-76.02	-4.11
Financing Cash Flow	-495.82	-544.04	-89.87	-113.36	-64.24	11.67
Foreign Exchange Rate Adjustments	160.55	145.21	-76.82	82.47	130.01	-73.13
Net Cash Flow	-409.75	-695.36	737.63	134.48	259.57	609.38
Free Cash Flow	1,159	1,053	1,040	516.52	302.24	1,007
Free Cash Flow Growth	49.22%	1.22%	101.38%	70.90%	-69.98%	437.58%
Free Cash Flow Margin	35.87%	35.23%	42.58%	24.79%	23.48%	60.59%
Free Cash Flow Per Share	18.67	16.29	15.78	7.83	4.58	15.28
Cash Interest Paid	6.07	4.86	3.71	2.3	1.84	3.29
Cash Income Tax Paid	49.7	47.62	158.23	227.44	113.49	242.57
Levered Free Cash Flow	1,010	867.97	789.22	305.1	259.8	768.36
Unlevered Free Cash Flow	1,022	878.38	795.71	308.6	261.04	769.39
Change in Net Working Capital	-237.33	-148.96	-227.64	323.71	59.81	-94.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q